<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2013-0-1-2-93-95</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. TREATMENT</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. ЛЕЧЕНИЕ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical results and life quality of patients with cervical cancer at a combined immunotherapy</article-title><trans-title-group xml:lang="ru"><trans-title>Клинические результаты и качество жизни больных раком шейки матки при сочетанной иммунотерапии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kenbayeva</surname><given-names>D. K.</given-names></name><name xml:lang="ru"><surname>Кенбаева</surname><given-names>Д. К.</given-names></name></name-alternatives><address><country country="KZ">Kazakhstan</country></address><email>dikenb@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazarev</surname><given-names>A. F.</given-names></name><name xml:lang="ru"><surname>Лазарев</surname><given-names>А. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Manambayeva</surname><given-names>Z. A.</given-names></name><name xml:lang="ru"><surname>Манамбаева</surname><given-names>З. А.</given-names></name></name-alternatives><address><country country="KZ">Kazakhstan</country></address><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">City Oncology Dispensary, Astana</institution></aff><aff><institution xml:lang="ru">Городской онкологический диспансер, Астана</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Altai Branch, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Barnaul</institution></aff><aff><institution xml:lang="ru">Алтайский филиал ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Барнаул</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Semey State Medical University</institution></aff><aff><institution xml:lang="ru">Государственный медицинский университет города Семей</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-05-21" publication-format="electronic"><day>21</day><month>05</month><year>2013</year></pub-date><issue>1-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>93</fpage><lpage>95</lpage><history><date date-type="received" iso-8601-date="2014-07-21"><day>21</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-21"><day>21</day><month>07</month><year>2014</year></date></history><permissions><copyright-year>2013</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/46">https://ojrs.abvpress.ru/ojrs/article/view/46</self-uri><abstract xml:lang="en"><p>In the publication some clinical results and characteristics of dynamics of life quality in patients with cervical cancer are presented at carrying out an immunotherapy. Complex inspection of 77 patients, including 40 – with IIB and 37 – with the III clinical stage is carried out. The increase in extent of primary tumor regression is revealed at a combination of beam the</p></abstract><trans-abstract xml:lang="ru"><p>Представлены некоторые клинические результаты и характеристики динамики качества жизни больных раком шейки матки при проведении иммунотерапии. Осуществлено комплексное обследование 77 больных, в том числе 40 – с IIВ и 37 – с III клини- ческой стадией. Выявлено увеличение степени регрессии первичной опухоли при сочетании лучевой терапии и иммунотерапии, значительный рост качества жизни по шкале Карновского и умеренное повышение 3-летней выживаемости.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>combined radiotherapy</kwd><kwd>specific immunotherapy</kwd><kwd>adoptive immunotherapy</kwd><kwd>3-year survival</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>сочетанная лучевая терапия</kwd><kwd>специфическая иммунотерапия</kwd><kwd>адоптивная иммунотерапия</kwd><kwd>3-летняя выживаемость</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Власов А.А., Новиков В.С., Карандашов В.В. Препараты, методы и схемы иммунотерапии опухолей. М.: Медицина, 2006. 152 с.</mixed-citation><mixed-citation xml:lang="ru">Власов А.А., Новиков В.С., Карандашов В.В. Препараты, методы и схемы иммунотерапии опухолей. М.: Медицина, 2006. 152 с.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature 2011;480(7378):480–9.</mixed-citation><mixed-citation xml:lang="ru">Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature 2011;480(7378):480–9.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Vanneman M., Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 2012;12(4):237–51.</mixed-citation><mixed-citation xml:lang="ru">Vanneman M., Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 2012;12(4):237–51.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Hockel M. Principles and practice of surgical treatment for cervical cancer: it's time for a change. Womens Health (Lond Engl) 2009;5(5):459–62.</mixed-citation><mixed-citation xml:lang="ru">Hockel M. Principles and practice of surgical treatment for cervical cancer: it's time for a change. Womens Health (Lond Engl) 2009;5(5):459–62.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
